Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Compass Therapeutics (CMPX) Other Non Operating Income (2023 - 2025)

Compass Therapeutics (CMPX) has disclosed Other Non Operating Income for 3 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 47.57% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Dec 2025, down 12.43% year-over-year, with the annual reading at $6.4 million for FY2025, 12.41% down from the prior year.
  • Other Non Operating Income hit $2.3 million in Q4 2025 for Compass Therapeutics, up from $1.6 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.3 million in Q4 2025 to a low of $1.2 million in Q2 2025.
  • Historically, Other Non Operating Income has averaged $1.8 million across 3 years, with a median of $1.9 million in 2023.
  • Biggest YoY gain for Other Non Operating Income was 47.57% in 2025; the steepest drop was 39.82% in 2025.
  • Year by year, Other Non Operating Income stood at $2.0 million in 2023, then decreased by 22.09% to $1.5 million in 2024, then surged by 47.57% to $2.3 million in 2025.
  • Business Quant data shows Other Non Operating Income for CMPX at $2.3 million in Q4 2025, $1.6 million in Q3 2025, and $1.2 million in Q2 2025.